Clinical Trials Directory

Trials / Completed

CompletedNCT05545046

Predictive Model for Pain After TACE

A Predictive Model for Pain After Transarterial Chemoembolization

Status
Completed
Phase
Study type
Observational
Enrollment
228 (actual)
Sponsor
Yantai Yuhuangding Hospital · Academic / Other
Sex
All
Age
34 Years – 87 Years
Healthy volunteers

Summary

The main aim of this study was to analyze the risk factors that helped to predict the pain after transarterial chemoembolization (TACE).This was a prospective observational study enrolled all hepatocellular carcinoma (HCC) patients undergoing TACE in our hospital. Pain score at rest was assessed after TACE by the patients themselves using a Visual Analogue Scale (VAS). Independent variables such as age, gender, tumor location, tumor size and number, drug delivery method and presence of portal vein tumor thrombosis (PVTT) were recorded and analyzed.

Conditions

Timeline

Start date
2019-09-01
Primary completion
2021-01-31
Completion
2021-01-31
First posted
2022-09-19
Last updated
2022-09-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05545046. Inclusion in this directory is not an endorsement.